What sector does Chemomab Therapeutics Ltd DRC (CMMB) operate in?
Chemomab Therapeutics Ltd DRC belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Chemomab Therapeutics Ltd DRC (CMMB) current stock price?
As of the latest data, Chemomab Therapeutics Ltd DRC stock price is $1.78, with a previous close of $1.75. Chemomab Therapeutics Ltd DRC gained $0.03 in the last trading session, representing a 1.71% increase.
What is Chemomab Therapeutics Ltd DRC (CMMB) current market capitalization?
Chemomab Therapeutics Ltd DRC market cap is approximately 12.82 million.
What is Chemomab Therapeutics Ltd DRC (CMMB) Earnings Per Share (EPS)?
The trailing EPS is -$1.44, and the forward EPS is -$0.03.
What is Chemomab Therapeutics Ltd DRC (CMMB) EBITDA?
Chemomab Therapeutics Ltd DRC EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.84 million.
Does Chemomab Therapeutics Ltd DRC (CMMB) pay dividends?
No. Chemomab Therapeutics Ltd DRC does not pay a dividend.
What is Chemomab Therapeutics Ltd DRC (CMMB) beta (volatility) score?
Chemomab Therapeutics Ltd DRC has a beta of 0.508, indicating lower volatility than the overall market.